163 related articles for article (PubMed ID: 23686826)
21. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.
Miao CH; Nakai H; Thompson AR; Storm TA; Chiu W; Snyder RO; Kay MA
J Virol; 2000 Apr; 74(8):3793-803. PubMed ID: 10729154
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer to the CNS using recombinant adeno-associated virus.
Stoica L; Ahmed SS; Gao G; Sena-Esteves M
Curr Protoc Microbiol; 2013; Chapter 14():14D.5.1-14D.5.18. PubMed ID: 23686825
[TBL] [Abstract][Full Text] [Related]
23. Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.
Kleven MD; Gomes MM; Wortham AM; Enns CA; Kahl CA
PLoS One; 2018; 13(4):e0194728. PubMed ID: 29621273
[TBL] [Abstract][Full Text] [Related]
24. Intracellular transport of recombinant adeno-associated virus vectors.
Nonnenmacher M; Weber T
Gene Ther; 2012 Jun; 19(6):649-58. PubMed ID: 22357511
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
[TBL] [Abstract][Full Text] [Related]
26. Controlled release strategies for rAAV-mediated gene delivery.
Rey-Rico A; Cucchiarini M
Acta Biomater; 2016 Jan; 29():1-10. PubMed ID: 26472612
[TBL] [Abstract][Full Text] [Related]
27. Efficient Transduction of Corneal Stroma by Adeno-Associated Viral Serotype Vectors for Implications in Gene Therapy of Corneal Diseases.
Lu Y; Ai J; Gessler D; Su Q; Tran K; Zheng Q; Xu X; Gao G
Hum Gene Ther; 2016 Aug; 27(8):598-608. PubMed ID: 27001051
[TBL] [Abstract][Full Text] [Related]
28. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
29. Recombinant adeno-associated viral vectors in the nervous system.
Burger C; Nash K; Mandel RJ
Hum Gene Ther; 2005 Jul; 16(7):781-91. PubMed ID: 16000060
[TBL] [Abstract][Full Text] [Related]
30. Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases.
Auricchio A; Rolling F
Curr Gene Ther; 2005 Jun; 5(3):339-48. PubMed ID: 15975011
[TBL] [Abstract][Full Text] [Related]
31. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.
Zuber C; Mitteregger G; Schuhmann N; Rey C; Knackmuss S; Rupprecht W; Reusch U; Pace C; Little M; Kretzschmar HA; Hallek M; Büning H; Weiss S
J Gen Virol; 2008 Aug; 89(Pt 8):2055-2061. PubMed ID: 18632978
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer in the lung using recombinant adeno-associated virus.
Gruntman AM; Mueller C; Flotte TR; Gao G
Curr Protoc Microbiol; 2012 Aug; Chapter 14():Unit14D.2. PubMed ID: 22875566
[TBL] [Abstract][Full Text] [Related]
33. A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.
Chtarto A; Bockstael O; Tshibangu T; Dewitte O; Levivier M; Tenenbaum L
Br J Clin Pharmacol; 2013 Aug; 76(2):217-32. PubMed ID: 23331189
[TBL] [Abstract][Full Text] [Related]
34. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
[TBL] [Abstract][Full Text] [Related]
35. Recombinant adeno-associated virus for muscle directed gene therapy.
Fisher KJ; Jooss K; Alston J; Yang Y; Haecker SE; High K; Pathak R; Raper SE; Wilson JM
Nat Med; 1997 Mar; 3(3):306-12. PubMed ID: 9055858
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.
Park YM; Woo S; Lee GT; Ko JY; Lee Y; Zhao ZS; Kim HJ; Ahn CW; Cha BS; Kim KS; Park CW; Lee HC
J Gene Med; 2005 May; 7(5):621-9. PubMed ID: 15651056
[TBL] [Abstract][Full Text] [Related]
37. Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes.
Kapturczak MH; Flotte T; Atkinson MA
Curr Mol Med; 2001 May; 1(2):245-58. PubMed ID: 11899074
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus and adeno-associated virus vectors.
Lai CM; Lai YK; Rakoczy PE
DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
[TBL] [Abstract][Full Text] [Related]
39. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy.
Sun JY; Chatterjee S; Wong KK
Curr Gene Ther; 2002 Dec; 2(4):485-500. PubMed ID: 12477257
[TBL] [Abstract][Full Text] [Related]
40. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
